Product Pathways - Cell Cycle / Checkpoint
PLK1 (208G4) Rabbit mAb #4513
| Applications | Reactivity | Sensitivity | MW (kDa) | Isotype |
|---|---|---|---|---|
| W IP | H R Mk | Endogenous | 62 | Rabbit IgG |
Applications Key:
W=Western Blotting
IP=Immunoprecipitation
Reactivity Key:
H=Human
R=Rat
Mk=Monkey
Species cross-reactivity is determined by Western blot.
Specificity / Sensitivity
PLK1 (208G4) Rabbit mAb detects endogenous levels of of total PLK1 protein.
Source / Purification
Monoclonal antibodies are produced by immunizing rabbits with a synthetic peptide (KLH-coupled) corresponding to residues near the carboxy terminus of human PLK1.
Background
At least 4 distinct polo-like kinases exist in mammalian cells: PLK1, PLK2, PLK3 and PLK4/SAK (1). PLK1 apparently plays many roles during mitosis, particularly in regulating mitotic entry and exit. The mitosis promoting factor (MPF), cdc2/cyclin B1, is activated by dephosphorylation of cdc2 (Thr14/Tyr15) by cdc25C. PLK1 phosphorylates cdc25C at Ser198 and cyclin B1 at Ser133 causing translocation of these proteins from the cytoplasm to the nucleus (2-5). PLK1 phosphorylation of Myt1 at Ser426 and Thr495 has been proposed to inactivate Myt1, one of the kinases known to phosphorylate cdc2 at Thr14/Tyr15 (6). Polo-like kinases also phosphorylate the cohesin subunit SCC1, causing cohesin displacement from chromosome arms that allow for proper cohesin localization to centromeres (7). Mitotic exit requires activation of the anaphase promoting complex (APC) (8), a ubiquitin ligase responsible for removal of cohesin at centromeres, and degradation of securin, cyclin A, cyclin B1, Aurora A and cdc20 (9). PLK1 phosphorylation of the APC subunits Apc1, cdc16 and cdc27 has been demonstrated in vitro and has been proposed as a mechanism by which mitotic exit is regulated (10,11).
- Nigg, E.A. (1998) Curr. Opin. Cell Biol. 10, 776-783.
- Toyoshima-Morimoto, F. et al. (2002) EMBO Rep. 3, 341-348.
- Toyoshima-Morimoto, F. et al. (2001) Nature 410, 215-220.
- Peter, M. et al. (2002) EMBO Rep. 3, 551-556.
- Jackman, M. et al. (2003) Nat. Cell Biol. 5, 143-148.
- Nakajima, H. et al. (2003) J. Biol. Chem. 278, 25277-25280.
- Sumara, I. et al. (2002) Mol. Cell 9, 515-525.
- Hauf, S. et al. (2001) Science 293, 1320-1323.
- Peters, J.M. (1999) Exp. Cell Res. 248, 339-349.
- Kraft, C. et al. (2003) EMBO J. 22, 6598-6609.
- Kotani, S. et al. (1998) Mol. Cell 1, 371-380.
Application References
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
Companion Products
- 4535 PLK1 Antibody
- 9529 Phospho-cdc25C (Ser198) Antibody
- 4131 Phospho-Cyclin B1 (Ser147) Antibody
- 4135 Cyclin B1 (V152) Mouse mAb
- 4282 Myt1 Antibody
- 7071 Phototope®-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
Rabbit Monoclonals Produced Using Epitomics® Technology, U.S. Patent No. 5,675,063.
This product is for in vitro research use only and is not intended for use in humans or animals. This product is not intended for use as therapeutic or in diagnostic procedures.